Mariann Alperin
Urogynecology and Reconstructive Pelvic Surgery · Encinitas, CANPI 1033266879
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (46.6%), education and travel and lodging — rather than concentrated in one kind of arrangement. 9 manufacturers reported payments, led by Intuitive Surgical at 50.1% of the total. Reporting peaked in 2023 at $8,994 and has fallen 97.6% since, to $217 in 2025.
Across 39 payments — averaging $453.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$9K
- Renovia Inc$8K
- AbbVie$197
- Coloplast$100
- Medtronic$69
- Baxter Healthcare$64
- plus $148 from 3 others
What the payments were for
- Consulting fees$8,25047%
- Travel & lodging$1,3267%
- Food & beverage$6204%
- Education$7,50042%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 13 | $8,870 |
| Renovia Inc | 4 | $8,250 |
| AbbVie | 8 | $197 |
| Coloplast | 5 | $100 |
| Medtronic | 2 | $69 |
| Baxter Healthcare | 1 | $64 |
| Boston Scientific | 3 | $61 |
| Axonics, Inc. | 2 | $57 |
| Urovant Sciences Inc | 1 | $30 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Leva Pelvic Floor Trainer$8,250
- DAVINCI XI$7,500
- Da Vinci Surgical System$1,250
How this compares
$17,697 in reported general payments places this provider in the 85th percentile of 130 urogynecology and reconstructive pelvic surgery providers in California.
See all urogynecology and reconstructive pelvic surgery providers in California →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 64 | $57,861 |
| GemtesaVibegron | 31 | $24,571 |
| Estradiol | 94 | $8,068 |
| EstringEstradiol | 12 | $6,040 |
| YuvafemEstradiol | 23 | $4,067 |
| Methenamine Hippurate | 22 | $2,984 |
| Trospium Chloride ErTrospium Chloride | 12 | $1,789 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 23 | $215 |
Paid to pharmacies, not to this prescriber.
Other urogynecology and reconstructive pelvic surgery in Encinitas
- Saad JumaEncinitas$19K
- Andrew BrillSan Francisco$345K
- Bilal KaakiRiverside$301K
- Savitha KrishnanMountain View$243K
- Peter CastilloLos Gatos$95K
- Bruce Kahnla Jolla$79K
- Jennifer GruenenfelderOrange$76K
- Traci ItoSan Francisco$68K
- Tanaz FerzandiLos Angeles$60K
- Sadikah BehbehaniCosta Mesa$53K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.